Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

EnClear Therapies

Founded in 2018, EnClear Therapies, Inc. is an early-stage neurological company developing device-based systems that 1. provide closed-loop delivery & monitoring of cerebrospinal fluids (CSF) and 2. therapeutic removal of toxic proteins. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).

  • Anthony R. DePasqua, MBA Co-Founder, President & CEO
  • Kasper Roet, Ph.D Co-Founder, Acting CSO
  • Kevin Eggan, Ph.D. Co-Founder, Scientific Advisor
  • William B. Gormley, MD, MPH, MBA Co-Founder, CMO
  • Jonathan Fleming, M.P.A. Co-Founder, Executive Chairman
  • Anthony R. DePasqua, MBA Co-Founder, President & CEO
  • Kasper Roet, Ph.D Co-Founder, Acting CSO
  • Kevin Eggan, Ph.D. Co-Founder, Scientific Advisor
  • William B. Gormley, MD, MPH, MBA Co-Founder, CMO
  • Jonathan Fleming, M.P.A. Co-Founder, Executive Chairman